Industry reports
Editor highlights

Ridaforolimus Comprehensive patent search

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Detailed I/E report of Fipronil export analysis

Detailed I/E report of Fipronil export analysis

  • $ 7 448
  • Industry report
  • by CCM International Limited
  • April 2014

To provide in-depth import /export analysis of Fipronil export analysis imported into or exported from China based on the China customs data. To help clients identify the import/export situation with exclusive research methods. To offer Fipronil export analysis's import/export volume, price, date, o ...

Industries: Generic Drug | Countries: China

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: Germany, India, Argentina, Brazil, Canada, Slovenia, Poland, Austria

Zentiva NV (Symbol:BAAZEN) SWOT Analysis, Strategy, Revenues and Profits

Zentiva NV (Symbol:BAAZEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Zentiva NV SWOT Analysis report provides you a strategic analysis ...

Industries: Generic Drug | Countries: Netherlands, Europe, Czech Republic

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Andreae-Noris Zahn AG SWOT Analysis report provides you a strategic ...

Industries: Generic Drug | Countries: Germany

Glenmark Generics Limited SWOT Analysis, Strategy, Revenues and Profits

Glenmark Generics Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug

Glenmark Generics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Glenmark Generics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • by MarketLine
  • April 2014
  • 67 pages

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Glenmark ...

Industries: Generic Drug

Glenmark Generics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Glenmark Generics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • by MarketLine
  • April 2014
  • 65 pages

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Glenmark ...

Industries: Generic Drug

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 108 pages

BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measures have taken their toll on all segments – including the pharmaceutical and healthcare market . Following regular price cuts for both branded and generic drugs throughout 2010 and 2011, more austerity ...

Industries: Generic Drug | Countries: Portugal

Abbott Laboratories - Strategy and SWOT Report

Abbott Laboratories - Strategy and SWOT Report

  • $ 175
  • Company report
  • by MarketLine
  • March 2014
  • 62 pages

Abbott Laboratories - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company. Features: - Detailed information on ...

Industries: Generic Drug | Countries: United States, Netherlands, Canada, Spain, Italy, France, Germany, Japan

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 114 pages

Includes 3 FREE quarterly updates BMI View: Belgium, much like most of the other regional industries, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical revenues because of patent expirations and the tightening operating environment. As part of its fiscal austerity ...

Industries: Generic Drug | Countries: Belgium

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.